-
News | 2023.01.30
Hepatitis B: towards better treatment for infected individuals in Africa
With 82 million people currently infected in Africa, the hepatitis B virus represents a major health threat. Early treatment can considerably reduce the risk of complications associated with the disease. In a recent analysis, scientists challenged the suitability of the diagnostic tests used in sub-Saharan Africa and called for more optimized treatment for local populations.
-
News | 2022.06.03
Tackling fungal infections more effectively through surveillance
A review study on the epidemiology of fungal infections in France opens new avenues for research to tackle these diseases more effectively.
-
Document de presse | 2016.11.08
The ADITEC Project on Advanced Immunization Technologies: an European Success Story
30 million Euros of funding, 42 public and private institutions have joined forces for next generation vaccines.The ADITEC project was presented today at the European Parliament as a Success Story.Development of novel immunisation technologies, adjuvants, vectors and delivery systems, formulations and vaccination methods optimised for different age groups, 207 scientific publications, and...
-
Document de presse | 2018.06.19
In-Cell-Art, the Institut Pasteur and BioNet-Asia announce the collaborative development of a dengue vaccine candidate
In-Cell-Art (ICA), a biotechnology company specialized in nanocarrier technologies, BioNet-Asia (BNA), an innovative vaccine developer, and the research team led by Dr. Anavaj Sakuntabhai at the Functional Genetics of Infectious Diseases Unit, Institut Pasteur Paris France, (GFMI-IP), announce today the development of Nanotaxi® formulated DNA vaccine to induce strong immune response against...
-
News | 2019.10.10
Economist Jim O’Neill, and other experts, discuss Antimicrobial Resistance at the Institut Pasteur
On September 26, 2019, as part of its Antimicrobial Resistance (AMR) initiative the Institut Pasteur hosted a round table discussion on the economic context of the fight against AMR. Lord Jim O’Neill, economist and author of the famous O’Neill report, a publication instrumental in putting AMR on the political landscape, was a key contributor, along with other experts representing public health,...
-
Document de presse | 2025.03.17
Hepatitis B: new rapid diagnostic test to halt mother-to-child transmission
Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting hepatitis B to their babies. This diagnostic tool could help eliminate hepatitis B by preventing mother-to-child transmission during childbirth, especially in low- and middle-income countries. Hepatitis B is...
-
Fiche maladie | 2024.12.09
Hidradenitis suppurativa
Hidradenitis suppurativa is a chronic autoinflammatory skin condition. It is characterized by recurring painful nodules, abscesses and suppurative lesions in areas where the skin rubs together, mainly the armpits, the skin folds of the groin, the buttocks and under the breasts. Symptoms occur in cycles or flare-ups, and the condition has a considerable impact on patients' quality of life, both...
-
Document de presse | 2017.10.12
Five Institut Pasteur scientists receive 2017 L'Oréal-UNESCO "For Women in Science" Fellowships
On October 11, 2017, five young scientists at the Institut Pasteur received 2017 L'Oréal-UNESCO "For Women in Science" Fellowships. Through their research, the three postdoctoral fellows and two PhD students are helping to advance scientific knowledge in the fields of child malnutrition, the immune system, vaccination, emerging diseases and psychotic disorders. These fellowships, awarded to...
-
News | 2020.05.14
LuLISA project, bioluminescence as a tool for human diagnostics, from allergy to Covid19
The LuLISA (Luciferase-Linked ImmunoSorbent Assay) research project aims developing high throughput serological tests for epidemiological studies at local, regional or nation scales. In a recent scientific publication, concerning the detection and dosing of IgE specific to several allergens in patients’ blood samples, the use of LuLISA proves to be a vastly improved detection method in...